Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate

References

• JunYJJadhavVBMinJHStable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphileInt J Pharm20124221–237438022079718
   PubMedGoogle Scholar
• HennenfentKLGovindanRNovel formulations of taxanes: a review. Old wine in a new bottle?Ann Oncol200617573574916364960
   PubMed Web of Science ®Google Scholar
• BisseryMCNohynekGSanderinkGJLavelleFDocetaxel (Taxotere): a review of preclinical and clinical experience. Part I: preclinical experienceAnticancer Drugs1995633393557670132
   PubMed Web of Science ®Google Scholar
• van OosteromATSchrijversDDocetaxel (Taxotere): a review of preclinical and clinical experience. Part II: clinical experienceAnticancer Drugs1995633563687670133
   PubMedGoogle Scholar
• HeLOrrGAHorwitzSBNovel molecules that interact with micro-tubules and have functional activity similar to TaxolDrug Discov Today20016221153116411700217
   PubMed Web of Science ®Google Scholar
• HerbstRSKhuriFRMode of action of docetaxel – a basis for combination with novel anticancer agentsCancer Treat Rev200329540741512972359
   PubMed Web of Science ®Google Scholar
• VasuDRMosesBJVyasKIsolation and characterization of impurities in docetaxelJ Pharm Biomed Anal200640361462216330175
   PubMedGoogle Scholar
• KumarDTomarRSDeoliaSKMitraMMukherjeeRBurmanACIsolation and characterization of degradation impurities in docetaxel drug substance and its formulationJ Pharm Biomed Anal20074341228123517126518
   PubMedGoogle Scholar
• NuijenBBoumaMSchellensJHBeijnenJHProgress in the development of alternative pharmaceutical formulations of taxanesInvest New Drugs200119214315311392448
   PubMedGoogle Scholar
• van ZuylenLVerweijJSparreboomARole of formulation vehicles in taxane pharmacologyInvest New Drugs200119212514111392447
   PubMed Web of Science ®Google Scholar
• PersohnECantaASchoepferSMorphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in ratsEur J Cancer200541101460146615913989
   PubMed Web of Science ®Google Scholar
• HaagRKratzFPolymer therapeutics: concepts and applicationsAngew Chem Int Ed Engl2006451198121516444775
   PubMed Web of Science ®Google Scholar
• KabanovAVOkanoTChallenges in polymer therapeutics: state of the art and prospects of polymer drugsAdv Exp Med Biol200351912712675205
   PubMed Web of Science ®Google Scholar
• ShinHCAlaniAWRaoDARockichNCKwonGSMulti-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugsJ Control Release2009140329430019409432
   PubMed Web of Science ®Google Scholar
• GaucherGMarchessaultRHLerouxJCPolyester-based micelles for the parenteral delivery of taxanesJ Control Release201014321219925835
   PubMed Web of Science ®Google Scholar
• CarstensMGde JongPHvan NostrumCFThe effect of core composition in biodegradable oligomeric micelles as taxane formulationsEur J Pharm Biopharm200868359660617949956
   PubMedGoogle Scholar
• ElsabahyMPerronMEBertrandNYuGELerouxJCSolubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micellesBiomacromolecules2007872250225717579476
   PubMed Web of Science ®Google Scholar
• LeeSWYunMHJeongSWDevelopment of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery systemJ Control Release201115526227121704664
   PubMed Web of Science ®Google Scholar
• ErnstingMJTangWLMacCallumNWLiSDPreclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse modelsBiomaterials20123351445145422079003
   PubMed Web of Science ®Google Scholar
• ErnstingMJFoltzWDUndzysETagamiTLiSDTumor-targeted drug delivery using MR-contrasted docetaxel-carboxymethylcellulose nanoparticlesBiomaterials2012333931394122369962
   PubMed Web of Science ®Google Scholar
• HoangBErnstingMJRoyAMurakamiMUndzysELiSDDocetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanismBiomaterials201559667625956852
   PubMed Web of Science ®Google Scholar
• HaradaMIwataCSaitoHNC-6301, polymeric micelle rationally optimized for effective release of docetaxel is potent but is less toxic than native docetaxel in vivoInt J Nanomedicine201272713272722745540
   PubMed Web of Science ®Google Scholar
• HuQRijckenCJBansalRHenninkWEStormGPrakashJComplete regression of breast tumor with a single dose of docetaxel-entrapped core-cross-linked polymeric micellesBiomaterials20155337037825890735
   PubMed Web of Science ®Google Scholar
• LogieJGaneshANAmanAMAl-awarRSShoichetMSPreclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse modelBiomaterials20171233047
   Google Scholar
• WickiAWitzigmannDBalasubramanianVHuwylerJNanomedicine in cancer therapy: challenge, opportunities, and clinical applicationsJ Control Release201520013815725545217
   PubMed Web of Science ®Google Scholar
• SohnYSJunYJPoly- and cyclotriphosphazenes as drug carriers for anticancer therapyAndrianovAKPolyphosphazenes for Biomedical ApplicationsHoboken, NJWiley2009249275
   Google Scholar
• AllcockHRPucherSRScopelianosAGPoly[(amino acid ester)phosphazenes] as substrates for the controlled release of small moleculesBiomaterials19941585635697948574
   PubMedGoogle Scholar
• InoueTChenGNakamaeKHoffmanASAn AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugsJ Control Release1998512–32212299685920
   PubMedGoogle Scholar
• SohnYSChoYHBeakHJungOSSynthesis and properties of low molecular weight polyphosphazenesMacromolecules19952875667568
   Web of Science ®Google Scholar
• LeeHJPardridgeWMMonoclonal antibody radiopharmaceuticals: cationization, pegylation, radimetal chelation, pharmacokinetics, and tumor imagingBioconjugate Chem200314546553
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
   PubMed Web of Science ®Google Scholar
• ZuJZMoonSHJeongBSohnYSThermosensitive micelles from PEGylated oligopeptidesPolymer20074836733678
   Google Scholar
• SongCWGriffinRParkHJInfluence of tumor pH on therapeutic responseTeicherBACancer Drug Resistance. (Chap. 2)Totowa, NJHumana Press20062142
   Google Scholar
• SalmasoSCalicetiPStealth properties to improve therapeutic efficacy of drug nanocarriersJ Drug Deliv2013201319
   Google Scholar
• BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
   PubMed Web of Science ®Google Scholar
• AllcockHRFullerTJMatsumuraKHydrolysis pathways for aminophosphazenesInorg Chem198221515521
   Web of Science ®Google Scholar
• YooHSLeeEAParkTGDoxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkagesJ Control Release2002821172712106973
   PubMed Web of Science ®Google Scholar